Abstract:Background Granzyme activity can affect the processing and stability of miRNAs within target cells. They also could induce changes in miRNA expression that impact apoptotic signaling. Granzyme-induced apoptosis might result in changes to the miRNA profile, which can further influence the apoptosis and inflammation processes. Objective The aim of this study was to bioinformatically analyze which miRNAs and transcription factors bind to the CDS and UTR regions of the granzyme family to regulate gene expression in relation to granzyme evolution and their association with human cancer diseases. Methods The expression patterns of granzyme genes were analyzed in various human tissues. MiRNAs binding to the CDS and UTR of the granzyme family were examined, and the transcription factors binding to these miRNAs binding sites were also analyzed. Cytoscape program was used to visualize and analyze the networks of interactions between granzyme mRNA and miRNAs. Additionally, the evolutionary patterns of the granzyme family in relation to miRNAs and transcription factors binding were investigated. Results Analysis of the expression patterns of the granzyme family in various human tissues shows that GZMA and GZMK are strongly expressed in lymph nodes. GZMB exhibits strong expression in the bone marrow, while GZMA is prominently expressed in the spleen. Twenty-two miRNAs bind to both GZMK and GZMB mRNA, while six miRNAs bind to both GZMK and GZMM mRNA. The only miRNA that binds to GZMK, GZMB, GZMM, and GZMA mRNA is hsa-miR-146a-5p. Transcription factors JUND, FOS, and JUN are distinctly interconnected with has-miR-5696 and GZMK. Association data between the granzyme family and cancers showed that various miRNAs were consistently implicated and exhibited either upregulation or downregulation. Conclusion Although the granzyme family possesses distinct genetic information, it shows relatively high expression levels in the lymph node, spleen, and bone marrow. Many miRNAs specifically regulate granzyme gene expression, and various transcription factors are involved. Analyzing the granzyme genes-miRNAs-transcription factors-related network will provide crucial insights into the mechanisms of cancer development and suppression.

Granzyme serine proteases in inflammation and rheumatic diseases

Granzymes in health and diseases: the good, the bad and the ugly

Granzyme B in Inflammatory Diseases: Apoptosis, Inflammation, Extracellular Matrix Remodeling, Epithelial-to-Mesenchymal Transition and Fibrosis

Role of the Granzyme Family in Rheumatoid Arthritis: Current Insights and Future Perspectives

Granzyme K drives a newly-intentified pathway of complement activation

Granzyme K+ CD8 T cells in autoimmunity

Granzyme B in aging and age-related pathologies

Perforin and granzymes: function, dysfunction and human pathology

Reassessing granzyme B: unveiling perforin-independent versatility in immune responses and therapeutic potentials

Research progress of granzyme B in tissue injury repair

Granzyme K+ CD8 T cells form a core population in inflamed human tissue

Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell–Mediated Cytotoxicity

Granule Leakage Induces Cell-Intrinsic, Granzyme B-Mediated Apoptosis in Mast Cells

Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells

Granzyme mRNA-miRNA interaction and its implication to functional impact

Serine proteases of the human immune system in health and disease

Selective Chemical Functional Probes of Granzymes A and B Reveal Granzyme B Is a Major Effector of Natural Killer Cell-Mediated Lysis of Target Cells

Identification of Serpinb1 As A Physiological Inhibitor of Human Granzyme H

Granzyme K mediates IL-23-dependent inflammation and keratinocyte proliferation in psoriasis

Biological Function Analysis of Monoclonal Antibodies Against Human Granulins in Vitro Using U251 Cells As a Model.

Granzyme B: A Novel Therapeutic Target for Treatment of Atopic Dermatitis